In-hospital switching from clopidogrel to prasugrel following thrombolysis for ST-elevation myocardial infarction: A 3-year single center experience

Tsahi T. Lerman, Doron Zahger, Jacob Arad, Harel Gilutz, Olga Reitblat, Avi Shimony

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Background: Prasugrel has proved its superiority over clopidogrel for reducing ischemic events among patients with ST elevation myocardial infarction (STEMI) undergoing urgent percutaneous coronary intervention (PCI). Data on switching of antiplatelet therapy in acute coronary syndrome patients in clinical practice are very limited. Importantly, the safety of in-hospital switching from clopidogrel to prasugrel following thrombolysis has not been addressed. Methods: We reviewed consecutive STEMI patients from February 2011 to April 2014 who were transferred to a tertiary center after receiving thrombolysis and a loading dose of clopidogrel in a non-PCI-capable center. If not contraindicated, these patients were reloaded and treated with prasugrel. A control group, three times larger, was selected from patients who underwent primary PCI and were initially treated with prasugrel. In-hospital outcomes were examined. Results: Cases (n=45, 13% female, mean age 56 years) and controls (n=135, 11% female, mean age 54 years) did not differ significantly with respect to MI location, left ventricular systolic function, and extent of coronary artery disease. Mean time from thrombolysis to prasugrel loading was 32±19 hours. No significant differences were found between cases and controls in TIMI major or minor bleeding (0% vs. 3%), overall mortality (0% vs. 1.5%), and hospitalization length (4.8 vs. 5.5 days). Conclusions: In-hospital reloading and subsequent maintenance therapy with prasugrel in patients who received thrombolysis and a loading dose of clopidogrel appears to be as safe as in STEMI patients managed by primary PCI; however, larger studies are needed to verify these results.

Original languageEnglish
Pages (from-to)271-276
Number of pages6
JournalEuropean Heart Journal: Acute Cardiovascular Care
Volume5
Issue number3
DOIs
StatePublished - 1 Jan 2016
Externally publishedYes

Keywords

  • Clopidogrel
  • Prasugrel
  • ST-elevation myocardial infarction
  • Thrombolysis

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'In-hospital switching from clopidogrel to prasugrel following thrombolysis for ST-elevation myocardial infarction: A 3-year single center experience'. Together they form a unique fingerprint.

Cite this